 Two Sigma Advisers LP bought a new stake in shares of BioXcel Therapeutics Inc NASDAQ:BTAI during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 27,200 shares of the companys stock, valued at approximately 1,442,000. Two Sigma Advisers LP owned approximately 0.12 ... 